Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

The Lancet Oncology

JournalCitation impact & published research

The Lancet Oncology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 12,160 works, 1,059,117 citations, an h-index of 521 and an APC (USD) of 6,300.

12,160
Works
1,059,117
Citations
521
h-index
6,300
APC (USD)

What are the most-cited papers on The Lancet Oncology?

ScholarIQmost cited works
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon, Florian Strasser, Stefan D. Anker, Ingvar Bosæus, Éduardo Bruera, Robin L. Fainsinger, Aminah Jatoi, Charles L. Loprinzi, Neil Macdonald, Giovanni Mantovani, Mellar P. Davis, Maurizio Muscaritoli, Faith D. Ottery, Lukas Radbruch, Paula Ravasco, Declan Walsh, Andrew Wilcock, Stein Kaasa, Vickie E. Baracos
The Lancet Oncology. 20115,722 Citations
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
The Lancet Oncology. 20125,545 CitationsOPEN ACCESS
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang, Wei‐jie Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He
The Lancet Oncology. 20204,605 CitationsOPEN ACCESS
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou, Yi‐Long Wu, Gongyan Chen, Jifeng Feng, Xiao-Qing Liu, Changli Wang, Shucai Zhang, Jie Wang, Songwen Zhou, Shengxiang Ren, Shun Lü, Li Zhang, Chengping Hu, Chunhong Hu, Yi Luo, Lei Chen, Ming Ye, Jianan Huang, Xiuyi Zhi, Yiping Zhang, Qingyu Xiu, Jun Ma, L Zhang, Changxuan You
The Lancet Oncology. 20114,112 Citations
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. Prado, Jessica Lieffers, Linda J. McCargar, Tony Reiman, Michael B. Sawyer, Lisa Martin, Vickie E. Baracos
The Lancet Oncology. 20083,230 Citations

Related on ScholarIQ

Definition and classification of cancer cachexia: an international consensus
Paper
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Paper
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Paper
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Paper
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Paper
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Paper
470M+ articles · free account